Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
+$744M |
| 2 |
Merck
MRK
|
+$570M |
| 3 |
GoDaddy
GDDY
|
+$352M |
| 4 |
CSX Corp
CSX
|
+$235M |
| 5 |
Edwards Lifesciences
EW
|
+$235M |
Top Sells
| 1 |
DexCom
DXCM
|
+$391M |
| 2 |
Biogen
BIIB
|
+$382M |
| 3 |
Broadcom
AVGO
|
+$353M |
| 4 |
Adobe
ADBE
|
+$293M |
| 5 |
Union Pacific
UNP
|
+$264M |
Sector Composition
| 1 | Technology | 24.39% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Dollar General
DG
$23.9B
| $132M | 0.07% |
1,210,669
+169,688
| +16% | +$18.5M |
|
327
Trinity Industries
TRN
$2.29B
| $132M | 0.07% |
5,002,085
-912,659
| -15% | -$24.1M |
|
|
CONE
328
DELISTED
CyrusOne Inc Common Stock
CONE
| $131M | 0.07% |
2,059,062
+274,885
| +15% | +$17.4M |
|
|
EGRX
329
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $130M | 0.07% |
1,881,501
-9,797
| -0.5% | -$679K |
|
330
D.R. Horton
DHI
$54.9B
| $129M | 0.07% |
3,065,946
-1,219,980
| -28% | -$51.5M |
|
|
MDSO
331
DELISTED
Medidata Solutions, Inc.
MDSO
| $129M | 0.07% |
1,762,023
-142,071
| -7% | -$10.4M |
|
|
DCP
332
DELISTED
DCP Midstream, LP
DCP
| $129M | 0.07% |
3,252,411
-93
| -0% | -$3.68K |
|
333
PagSeguro Digital
PAGS
$2.78B
| $129M | 0.07% |
4,647,944
+3,373,784
| +265% | +$93.4M |
|
334
Avnet
AVT
$4.45B
| $126M | 0.07% |
2,816,660
-170,811
| -6% | -$7.65M |
|
|
BHVN
335
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $125M | 0.07% |
3,336,916
+37,616
| +1% | +$1.41M |
|
336
United Rentals
URI
$62.4B
| $125M | 0.07% |
761,504
-234,237
| -24% | -$38.3M |
|
337
Ralph Lauren
RL
$18.7B
| $124M | 0.07% |
903,894
+16,265
| +2% | +$2.24M |
|
|
GBT
338
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $124M | 0.07% |
3,268,038
-886,347
| -21% | -$33.7M |
|
339
LKQ Corp
LKQ
$8.39B
| $122M | 0.07% |
3,851,179
-830,797
| -18% | -$26.3M |
|
340
Icon
ICLR
$13.8B
| $121M | 0.06% |
788,206
+37,851
| +5% | +$5.82M |
|
341
MarketAxess Holdings
MKTX
$6.99B
| $121M | 0.06% |
677,628
-2,707
| -0.4% | -$483K |
|
342
IBM
IBM
$239B
| $121M | 0.06% |
836,503
+571,182
| +215% | +$82.6M |
|
|
TIF
343
DELISTED
Tiffany & Co.
TIF
| $120M | 0.06% |
931,173
+140,021
| +18% | +$18.1M |
|
344
Akamai
AKAM
$11.3B
| $120M | 0.06% |
1,640,017
+477,914
| +41% | +$35M |
|
345
M&T Bank
MTB
$31.1B
| $120M | 0.06% |
727,518
+371,263
| +104% | +$61.1M |
|
346
Omnicell
OMCL
$1.49B
| $120M | 0.06% |
1,662,720
+148,741
| +10% | +$10.7M |
|
347
Newmont
NEM
$83.2B
| $119M | 0.06% |
3,948,762
+350,156
| +10% | +$10.6M |
|
|
NUVA
348
DELISTED
NuVasive, Inc.
NUVA
| $119M | 0.06% |
1,674,726
-414,324
| -20% | -$29.4M |
|
349
Arista Networks
ANET
$176B
| $119M | 0.06% |
7,136,320
+346,896
| +5% | +$5.76M |
|
350
Nutrien
NTR
$27.9B
| $118M | 0.06% |
2,050,841
+73,135
| +4% | +$4.22M |
|